Skip to main content
. 2017 Oct 20;8:1060. doi: 10.1038/s41467-017-01168-1

Fig. 4.

Fig. 4

PTP4A1 silencing protects mice from dermal fibrosis. Masson’s trichrome-stained skin sections from bleomycin-treated mice. Images are representative of 16 WT, 16 PTP4A1 KO, and 14 PTP4A1 KO/PTP4A2 Het mice (a), or 5 COL1A1Cre/PTP4A1fl/fl and 9 COL1A1Cre+/PTP4A1fl/fl tamoxifen-induced mice (e). Graphs show mean ± SEM dermal thickness (b, g, see yellow bars in a and e), skin collagen concentration (c, h), and ACTA2 mRNA relative expression (d, i). f PTP4A1 mRNA relative expression in whole skin (left graph) or in isolated mouse dermal fibroblasts (right graph) from two COL1A1Cre/PTP4A1fl/fl or three COL1A1Cre+/PTP4A1fl/fl mice. Mann–Whitney test. Scale bar, 50 μm